Thank you to our 2023 Sponsors
Our first networking event by Swiss HLG held at the Novartis Pavillon on the 21st November was a great success! The topic “Microbiome – from traditional Chinese remedies to the third phase of therapeutic objectives” was the theme for the evening.
Thanks to all speakers Ana Montalban-Arques, Gemma Henderson, Tomas de Wouters and Laura Bonini for inspiring talks, to the attendees for joining in and exchanging and the whole Swiss HLG board for the organisation. Last but not least to Jean-Marc Séquier for hosting and moderating the panel.
We have some exciting news: Swiss HLG would like to extend a warm welcome to our new co-opted board member Nathalie Jenni. With her close to 20 years of combined valuable experience and expertise as both in-house counsel and external independent attorney, Nathalie will bring new insights, ideas and opportunities to Swiss HLG and our members. We eagerly look forward to her input and contribution to our association.
Initiating her career at a commercial law firm in Basel, Switzerland, with her primary area of practice being contractual law and the pharmaceutical industry, Nathalie then moved to the biopharma industry where she spent 15 years as an in-house counsel. For over 12 years, Nathalie complemented business development teams, as the responsible signatory for legal matters as well as being a co-shaping and co-deciding part of the negotiation team for strategic and business relevant deals. Becoming independent at the end of 2021, she founded her own company in 2022.
Nathalie is a Swiss attorney and currently acts as a legal consultant and attorney for start-ups and SMEs in the biopharma field. She’s specialized on matters related to preclinical development and business development, with core expertise in and passion for complex licensing, collaboration and co-development agreements as well as option deals for compounds, cell therapies and vaccines.
Nathalie comments ¨I am delighted to join the Swiss HLG and help to foster a vibrant community of dealmakers in Switzerland, committed to enabling fair, balanced and beneficial deals¨.
Please join us for our inaugural Swiss HLG Basel Networking gathering on November 21st, where we will explore the topic of "Microbiome - from traditional Chinese remedies to the third phase of therapeutic objectives."
In recent years, the Microbiome has garnered significant attention as an emerging therapeutic approach. Nevertheless, many initiatives encounter challenges at various stages of their development. Throughout the evening, our goal is to delve deeper into the current landscape of Microbiome research, the ongoing transactions, as well as the strategies and novel business models being formulated by companies. Additionally, there will be plenty of opportunities to connect with fellow attendees during a networking apero in the exquisite setting of the Novartis Pavilion.
Register here > Swiss HLG Basel Networking Event
SPEAKERS:
• Ana Montalban-Arques, CEO and co-founder at Recolony AG
• Tomas de Wouters, CEO and founder at PharmaBiome
• Laura Bonini, Principal at IQVIA
• Gemma Henderson, Project and Portfolio Management at Bacthera
PROGRAMME AND REGISTRATION:
Event registration and welcome: 5.30pm - 6.00pm
Panel discussion with Q&A: 6.00pm - 7.30pm
Apero with networking 7.30pm - 9.00pm
Swiss HLG Members >>> Free
Non members >>> CHF 25,-
Join us for our 1st Basel Networking event, where we will discuss "Microbiome – from ancient Chinese cures to the third wave of therapeutic targets."
The Microbiome as a new therapeutic modality has been receiving lots of attention over the past years. Still, we see many concepts fail at various stages in development. Over the course of this evening, we aim to learn more about the current Microbiome space, the deals taking place and how companies are developing strategies and building new business models. And of course, there will be ample time to network over an Apero Riche at the beautiful Novartis Pavillon.
SPEAKERS:
• Dr. Ana Montalban-Arques, CEO and co-founder of Recolony AG
• Dr. Tomas de Wouters, CEO and founder PharmaBiome
• Laura Bonini, Principal at IQVIA
PROGRAMME AND REGISTRATION 21ST NOVEMBER 2023:
Event registration desk open and welcome: 5.30pm - 6.00pm
Panel discussion with Q&A: 6.00pm - 7.30pm
Apero with networking 7.30pm - 9.00pm
Swiss HLG Members >>> Free
Non members >>> CHF 25,-
We had a very successful webinar yesterday with around 100 participants. Asnen Cassam-Chenaï and Andreas Wallnoefer, both had very insightful and engaging presentations followed by a Q&A. We received very positive feedback and we would like to thank our speakers, Andreas and Asnen, as well as all those that participated to this event. We would also like to thank Luis Vieira from Swiss HLG and Magali Pernot from PLCF for co-organizing this event. We look forward to organising similar events in future that provide valuable insights for BD professionals everywhere.
SAVE THE DATE CONFERENCE 2024
Mark your calendars and save the date! The annual flagship Swiss HLG Conference is back, and it's all about "Back to deal-making!" Join us from 26th-28th May in stunning Montreux to discuss the topic, network with industry leaders, and explore new opportunities.
Don't miss out on this exciting event!
Sign up and join in on the joint PLCF - Swiss HLG free webinar on the 3rd October:
ROLE OF PRIVATE EQUITY IN SUPPORTING & BUILDING HEALTHCARE COMPANIES.
We have two wonderful speakers, Asnen Cassam-Chenaï, Principal at Eurazeo Nov Santé, and Andreas Wallnoefer, Partner at Jeito Capital and Board Director in Biotech.
Asnen will talk about a new financing tool to support the transformation of the French healthcare industry, while Andreas will review models of partnership between private equity and entrepreneurs.
The webinar is scheduled for 1.5 hours at 9am on 3rd October 2023, with each presentation lasting around 30 minutes, followed by a Q&A session.
Join us for our 2nd after work networking event on the 14th September at Campus Biopôle in Swiss Romandie in collaboration with Biopôle Lausanne and BioAlps - Swiss Health Valley. There will be a 1-hour panel presentation and discussion followed by a networking apero.
SPEAKERS:
• Catherine Pickering from iOnctura
• Lambert Potin from Debiopharm
• Sébastien Chenuet from Ichnos Pharma
• Veronica Gambillara Fonck from Pureos Bioventures
PROGRAMME AND REGISTRATION:
Event registration and welcome: 5.30pm - 6.00pm
Panel presentation with Q&A: 6.00pm - 7.00pm
Apero with networking: 7.00pm - 8.30pm
Thu, 14 Sep 2023 17:30 - 20:30 - Campus Biopôle Alanine Meeting Room , Building Alanine, Ground floor 5 Route de la Corniche 1066 Epalinges
Swiss HLG/Biopôle members >>> Free
Non members >>> CHF 25,-